Nah referring to some of the big Canadian Canna Co's. Have a look a some of the financial reports coming from the big boys, Aurora revenue up, margin down... That'll continue to happen.. Smart money ain't in the raw material long term, it's in products with IP protection, science support, value-add goods ect. But even if it's not Canadian Canna Co's, consider this... GSK has the highest number of completed clinical trials for acne and they spent $5bn on pharma R&D alone in 2017... What's a few hundred mill in 2020 on a Phase 2 acne asset which is less than 10% of their total R&D budget!!
Bot Chart, page-240
-
- There are more pages in this discussion • 200 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.005(1.41%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.0¢ | 34.0¢ | $843.9K | 2.414M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 76260 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 149185 | 4 |
View Market Depth
| Last trade - 16.10pm 27/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
